Search Results - "Post-Exposure Prophylaxis methods"
-
1
Authors: et al.
Contributors: et al.
Source: Acta clinica Belgica, Vol. 73, no. 4, p. 275-280 (2018)
Subject Terms: Male, 0301 basic medicine, HIV Infections/drug therapy, risk assessment, HIV, HIV Infections, Sciences bio-médicales et agricoles, Post-exposure prophylaxis, Risk Assessment, Anti-Retroviral Agents/administration & dosage, 3. Good health, 03 medical and health sciences, Risk-Taking, 0302 clinical medicine, Anti-Retroviral Agents, Belgium, post-exposure prophylaxis, Post-Exposure Prophylaxis/methods, Prevalence, Humans, Female, Post-Exposure Prophylaxis, Belgium/epidemiology
File Description: No full-text files
Access URL: https://pubmed.ncbi.nlm.nih.gov/29429390
https://research.itg.be/en/publications/belgian-guidelines-for-non-occupational-hiv-post -exposure -prophyl
https://www.tandfonline.com/doi/abs/10.1080/17843286.2018.1428506
https://researchportal.vub.be/en/publications/belgian-guidelines-for-non-occupational-hiv-post -exposure -prophyl
https://www.ncbi.nlm.nih.gov/pubmed/29429390
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/286487/Details
https://pubmed.ncbi.nlm.nih.gov/29429390/
https://hdl.handle.net/2078.1/208867
https://biblio.vub.ac.be/vubir/belgian-guidelines-for-nonoccupational-hiv-postexposure-prophylaxis -2017(548df59e-7701-40fa-8661-379783e0884f).html -
2
Authors: et al.
Source: Faculty Publications
Subject Terms: rabies, United States, prophylaxis, postexposure prophylaxis, Antibodies, Viral (administration & dosage), Delivery of Health Care, Humans, Post-Exposure Prophylaxis (methods), Rabies (prevention & control), Rabies Vaccines (administration & dosage), Rabies virus (immunology), Pharmacy and Pharmaceutical Sciences
File Description: application/pdf
Relation: https://scholarcommons.sc.edu/phar_facpub/18; https://scholarcommons.sc.edu/context/phar_facpub/article/1017/viewcontent/journal.pntd.0009461.pdf
-
3
Authors: et al.
Source: ISSN: 2044-6055 ; BMJ Open, vol. 10, no. 11 (2020) e040110.
Subject Terms: info:eu-repo/classification/ddc/613, info:eu-repo/classification/ddc/616, info:eu-repo/classification/ddc/616.07, info:eu-repo/classification/ddc/618, Antiviral Agents/therapeutic use, Betacoronavirus, COVID-19, Coronavirus Infections/prevention & control, Drug Combinations, Humans, Lopinavir/therapeutic use, Pandemics/prevention & control, Pneumonia, Viral/prevention & control, Post-Exposure Prophylaxis/methods, Randomized Controlled Trials as Topic, Ritonavir/therapeutic use, SARS-CoV-2, Switzerland
Relation: info:eu-repo/semantics/altIdentifier/pmid/33184083; unige:155005
Availability: https://archive-ouverte.unige.ch/unige:155005
-
4
Authors: et al.
Contributors: et al.
Source: EMBO Molecular Medicine
EMBO Mol Med
EMBO Molecular Medicine, Vol 8, Iss 4, Pp 407-421 (2016)
EMBO Molecular Medicine, 8 (4)Subject Terms: 0301 basic medicine, Medicine (General), rabies, bat, QH426-470, Antibodies, Viral, Chiroptera, Chordata, Research Articles, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, 0303 health sciences, Antibodies, Monoclonal/administration & dosage/*immunology/isolation &, Antibodies, Monoclonal, Rabies virus/*immunology, Biodiversity, 3. Good health, [SDV] Life Sciences [q-bio], Treatment Outcome, Mammalia, Molecular Medicine, human monoclonal antibody, Post-Exposure Prophylaxis, Lyssaviruses, Immunologic Factors/administration & dosage/*immunology/isolation & purification, purification, Rabies, Human monoclonal antibody, Post-exposure prophylaxis, lyssaviruses, bats, 03 medical and health sciences, R5-920, Antibodies, Neutralizing/administration & dosage/*immunology/isolation &, Genetics, post-exposure prophylaxis, Antibodies, Viral/administration & dosage/*immunology/isolation & purification, Immunologic Factors, Animals, Humans, Animalia, QR355, Mesocricetus, Immunization, Passive, post‐exposure prophylaxis, Antibodies, Neutralizing, Survival Analysis, Post-Exposure Prophylaxis/*methods, Rabies/*prevention & control, Immunization, Passive/methods, Disease Models, Animal, Rabies virus
File Description: application/pdf; application/application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/26992832
http://sro.sussex.ac.uk/id/eprint/73250/1/407.full.pdf
https://doaj.org/article/e80ee3d7220543d9872041b2b9068ffa
http://sro.sussex.ac.uk/id/eprint/73250/
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26992832/
https://doc.rero.ch/record/326885/files/DeBenedictis_EMM_2016.pdf
https://www.embopress.org/doi/pdf/10.15252/emmm.201505986
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818751/
https://hal-pasteur.archives-ouvertes.fr/pasteur-01429575/document
https://pasteur.hal.science/pasteur-01429575v1
https://doi.org/10.15252/emmm.201505986
https://pasteur.hal.science/pasteur-01429575v1/document
http://hdl.handle.net/20.500.11850/114473
http://doc.rero.ch/record/326885/files/DeBenedictis_EMM_2016.pdf -
5
Authors: et al.
Contributors: et al.
Source: ISSN: 1473-3099.
Subject Terms: MESH: Animals, MESH: Bites and Stings / virology, MESH: Rabies / prevention & control, MESH: Rabies / virology, MESH: Child, Preschool, MESH: Rabies Vaccines / economics, MESH: Rabies Vaccines / therapeutic use, MESH: Rabies virus / immunology, MESH: Rabies virus / isolation & purification, MESH: Vaccination / economics, MESH: World Health Organization, MESH: Cost-Benefit Analysis / methods, MESH: Incidence, MESH: Dog Diseases / prevention & control, MESH: Dogs, MESH: Endemic Diseases / prevention & control, MESH: Female, MESH: Humans, MESH: Immunoglobulins / therapeutic use, MESH: Male, MESH: Models, Economic, MESH: Post-Exposure Prophylaxis / economics, MESH: Post-Exposure Prophylaxis / methods, MESH: Quality-Adjusted Life Years, MESH: Rabies / epidemiology, MESH: Rabies / mortality, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Relation: info:eu-repo/semantics/altIdentifier/pmid/30472178; PUBMED: 30472178; PUBMEDCENTRAL: PMC6300480
Availability: https://hal.science/hal-02868805
https://hal.science/hal-02868805v1/document
https://hal.science/hal-02868805v1/file/The%20potential%20effect%20of%20improved%20provision%20of%20rabies%20post-exposure%20prophylaxis%20in%20Gavi-eligible.pdf
https://doi.org/10.1016/S1473-3099(18)30512-7 -
6
Authors: et al.
Contributors: et al.
Source: American Journal of Infection Control. 43:1292-1295
Subject Terms: Male, Isoniazid/therapeutic use, Seoul, Antitubercular Agents/therapeutic use, Thoracic, Health Personnel, Antitubercular Agents, Chemoprophylaxis, Chemoprevention, Tertiary Care Centers, Pulmonary/diagnosis, Young Adult, 03 medical and health sciences, Neonatal intensive care unit, 0302 clinical medicine, Disease Transmission, Pulmonary/transmission, Neonatal, Intensive Care Units, Neonatal, Disease Transmission, Infectious, Isoniazid, Tuberculosis, Humans, Cross Infection/transmission, Tuberculosis, Pulmonary, Pulmonary/prevention & control, Cross Infection, Tuberculin Test, Infectious, Pulmonary tuberculosis, Seoul/epidemiology, Infant, Newborn, Infant, Cross Infection/prevention & control, Postexposure prophylaxis, Newborn, Chemoprevention/methods, 3. Good health, Radiography, Intensive Care Units, Treatment Outcome, Post-Exposure Prophylaxis/methods, Cross Infection/diagnosis, Female, Radiography, Thoracic, Post-Exposure Prophylaxis
Access URL: https://pubmed.ncbi.nlm.nih.gov/26307044
https://mdanderson.elsevierpure.com/en/publications/nosocomial-exposure -to-active-pulmonary-tuberculosis-in-a-neonata
http://www.sciencedirect.com/science/article/pii/S0196655315007919
https://www.ncbi.nlm.nih.gov/pubmed/26307044
https://europepmc.org/article/MED/26307044
https://www.sciencedirect.com/science/article/pii/S0196655315007919
https://dspace.ewha.ac.kr/handle/2015.oak/217524 -
7
Authors: et al.
Source: Mieras, L F, Taal, A T, van Brakel, W H, Cambau, E, Saunderson, P R, Smith, W C S, Prakoeswa, C R S, Astari, L, Scollard, D M, do Nascimento, D C, Grosset, J, Kar, H K, Izumi, S, Gillini, L, Virmond, M C L & Sturkenboom, M G G 2018, 'An enhanced regimen as post-exposure chemoprophylaxis for leprosy : PEP+', BMC Infectious Diseases, vol. 18, no. 1, 506. https://doi.org/10.1186/s12879-018-3402-4
Subject Terms: Anti-Bacterial Agents/therapeutic use, Clarithromycin/therapeutic use, Fluoroquinolones/therapeutic use, Humans, Leprosy/drug therapy, Netherlands, Post-Exposure Prophylaxis/methods, Rifampin/therapeutic use
File Description: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/30290790; info:eu-repo/semantics/altIdentifier/wos/000446437200001; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/a431da5a-5b51-43c2-b166-c342872ef47b; info:eu-repo/semantics/altIdentifier/pissn/1471-2334; info:eu-repo/semantics/altIdentifier/eissn/1471-2334
Availability: https://hdl.handle.net/11370/a431da5a-5b51-43c2-b166-c342872ef47b
https://research.rug.nl/en/publications/a431da5a-5b51-43c2-b166-c342872ef47b
https://doi.org/10.1186/s12879-018-3402-4
https://pure.rug.nl/ws/files/71538049/s12879_018_3402_4.pdf
https://www.scopus.com/pages/publications/85054446526 -
8
Authors: et al.
Source: PLoS Negl Trop Dis
PLoS Neglected Tropical Diseases, Vol 15, Iss 7, p e0009461 (2021)Subject Terms: Rabies (prevention & control), Rabies, RC955-962, rabies, Post-Exposure Prophylaxis (methods), Antibodies, Viral, Antibodies, 03 medical and health sciences, 0302 clinical medicine, Arctic medicine. Tropical medicine, Humans, Rabies Vaccines (administration & dosage), Pharmacy and Pharmaceutical Sciences, Viral (administration & dosage), United States, Viewpoints, Rabies Vaccines, Rabies virus, prophylaxis, Public aspects of medicine, RA1-1270, Post-Exposure Prophylaxis, postexposure prophylaxis, Rabies virus (immunology), Delivery of Health Care
File Description: application/pdf
Access URL: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009461&type=printable
https://pubmed.ncbi.nlm.nih.gov/34264942
https://doaj.org/article/e93a1c34f1534711bd7ec9007dddd0ae
https://scholars.houstonmethodist.org/en/publications/rabies-postexposure-prophylaxis -in-the-united-states-opportunitie
https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1064&context=pps_facpub
https://europepmc.org/article/MED/34264942
https://uknowledge.uky.edu/pps_facpub/65/
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009461
https://pubmed.ncbi.nlm.nih.gov/34264942/ -
9
Authors: et al.
Subject Terms: Humans, Female, Anti-HIV Agents/therapeutic use, HIV Infections/virology, HIV-1/genetics, Mutation, HIV Infections/drug therapy, Alleles, Treatment Failure, HIV Infections/diagnosis, Drug Resistance Viral/genetics, Pregnancy, Pregnancy Complications Infectious/drug therapy, Pregnancy Complications Infectious/virology, High-Throughput Nucleotide Sequencing/methods, Real-Time Polymerase Chain Reaction/methods, Infectious Disease Transmission, Vertical/prevention & control, Post-Exposure Prophylaxis/methods, Pregnancy Complications Infectious/classification, Pregnancy Complications Infectious/diagnosis, Prognosis, Tanzania, 610 Medizin, ddc:610
File Description: application/pdf
Relation: http://edoc.rki.de/oa/articles/reYYJ2uxiK7dQ/PDF/22dwXmiRgYKH2.pdf; http://edoc.rki.de/176904/2202; http://dx.doi.org/10.25646/2127
-
10
Authors: et al.
Subject Terms: Antiviral Agents/therapeutic use, Betacoronavirus, COVID-19, Coronavirus Infections/prevention & control, Drug Combinations, Humans, Lopinavir/therapeutic use, Pandemics/prevention & control, Pneumonia, Viral/prevention & control, Post-Exposure Prophylaxis/methods, Randomized Controlled Trials as Topic, Ritonavir/therapeutic use, SARS-CoV-2, Switzerland, clinical trials, epidemiology, infectious diseases, preventive medicine
File Description: application/pdf
Relation: BMJ Open; https://iris.unil.ch/handle/iris/86408; serval:BIB_395E5B616F52; 000595708200034
-
11
Authors: et al.
Contributors: et al.
Source: ISSN: 1935-2727.
Subject Terms: Saliva/virology, Skin/virology, Animals, Chiroptera/virology, Female, French Guiana/epidemiology, Health Personnel, Humans, Male, Post-Exposure Prophylaxis/methods, Rabies/*diagnosis/*epidemiology/prevention & control/virology, Rabies Vaccines/administration & dosage, Rabies virus/*isolation & purification, MESH: Animals, MESH: Chiroptera, MESH: Post-Exposure Prophylaxis, MESH: Rabies, MESH: Rabies Vaccines, MESH: Rabies virus, MESH: Saliva, MESH: Skin, MESH: Female, MESH: French Guiana, MESH: Health Personnel, MESH: Humans, MESH: Male, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Relation: info:eu-repo/semantics/altIdentifier/pmid/22363830; PUBMED: 22363830; PUBMEDCENTRAL: PMC3283561
-
12
Authors: et al.
Contributors: et al.
Source: ISSN: 1871-5265 ; Infectious Disorders - Drug Targets ; https://pasteur.hal.science/pasteur-01491353 ; Infectious Disorders - Drug Targets, 2011, 11 (3), pp.251--299. ⟨10.2174/187152611795768079⟩.
Subject Terms: Rabies, Post-Exposure Prophylaxis, Rabies Vaccines, Rabies virus, Animals, Antiviral Agents, Dogs, Encephalitis, Humans, Zoonoses, MESH: Animals, MESH: Antiviral Agents/administration & dosage, MESH: Encephalitis/immunology, MESH: Encephalitis/prevention & control, MESH: Encephalitis/virology, MESH: Post-Exposure Prophylaxis/methods, MESH: Rabies/drug therapy, MESH: Rabies/immunology, MESH: Rabies/prevention & control, MESH: Rabies/virology, MESH: Rabies Vaccines/administration & dosage, MESH: Rabies Vaccines/immunology, MESH: Rabies virus/immunology, MESH: Zoonoses/virology, MESH: Antiviral Agents/therapeutic use, MESH: Encephalitis/drug therapy, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Relation: info:eu-repo/semantics/altIdentifier/pmid/21488832; PUBMED: 21488832
-
13
Authors: et al.
Contributors: et al.
Source: ISSN: 1473-3099.
Subject Terms: MESH: Adolescent, MESH: Adult, MESH: Humans, MESH: Immunization Schedule, MESH: Injections, Intradermal, MESH: Male, MESH: Neutralization Tests, MESH: Post-Exposure Prophylaxis* / methods, MESH: Rabies / prevention & control, MESH: Rabies Vaccines / administration & dosage, MESH: Rabies virus / immunology, MESH: Vaccination, MESH: Age Factors, MESH: Young Adult, MESH: Animals, MESH: Antibodies, Neutralizing / immunology, Viral / immunology, MESH: Child, MESH: Cohort Studies, MESH: Dogs, MESH: Female, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Relation: info:eu-repo/semantics/altIdentifier/pmid/31570311; PUBMED: 31570311
Availability: https://hal.science/hal-02866747
https://doi.org/10.1016/S1473-3099(19)30311-1 -
14
Authors: et al.
Subject Terms: human monoclonal antibody, lyssaviruses, post-exposure prophylaxis, rabies, Animals, Antibodies, Monoclonal/administration & dosage/*immunology/isolation &, Neutralizing/administration & dosage/*immunology/isolation &, Viral/administration & dosage/*immunology/isolation & purification, Disease Models, Animal, Humans, Immunization, Passive/methods, Immunologic Factors/administration & dosage/*immunology/isolation & purification, Mesocricetus, Post-Exposure Prophylaxis/*methods, Rabies virus/*immunology, Rabies/*prevention & control, Survival Analysis, Treatment Outcome, purification, Biodiversity, Mammalia, Chiroptera, Chordata, Animalia, bats, bat
Relation: hash://md5/e851ab8890636d5530a7e93fff75a44f; hash://sha256/6b6c00dbdefc1e107540f08524b2f753bb903880c58a799ee0590346e5674f97; zotero://select/groups/5435545/items/TICR95FN; https://zotero.org/groups/5435545/items/TICR95FN; https://linker.bio/cut:hash://md5/ac66d34c91900d476ba536e4622d1506!/b39344-41925; hash://md5/ce1e7618f237ff56e74d51f496e811a3; https://zenodo.org/communities/batlit/; https://zenodo.org/communities/biosyslit/; https://zenodo.org/records/13529801; oai:zenodo.org:13529801; urn:lsid:zotero.org:groups:5435545:items:TICR95FN; https://doi.org/10.5281/zenodo.13529801
Full Text Finder 
Nájsť tento článok vo Web of Science 
Full Text